{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:25:44Z","timestamp":1740122744170,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007197","name":"U.S. Public Health Service","doi-asserted-by":"publisher","award":["UM1 AI069453"],"award-info":[{"award-number":["UM1 AI069453"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10461-022-03867-3","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:04:18Z","timestamp":1666796658000},"page":"1314-1320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Varied Screening Risk Criteria and HIV Incidence in Phase 1 and 2 HIV Vaccine Trials in South Africa"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5231-9951","authenticated-orcid":false,"given":"Fatima","family":"Laher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennedy","family":"Otwombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofentse","family":"Mokwena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"issue":"2","key":"3867_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/1740774515602868","volume":"13","author":"RA Johnson","year":"2016","unstructured":"Johnson RA, Rid A, Emanuel E, Wendler D. Risks of phase I research with healthy participants: a systematic review. Clin Trials. 2016;13(2):149\u201360.","journal-title":"Clin Trials"},{"key":"3867_CR2","unstructured":"Data UNAIDSUNAIDS. 2020. Available at: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2020_aids-data-book_en.pdf. Accessed August 5, 2020."},{"key":"3867_CR3","unstructured":"NIH U.S. National Library of Medicine. Map of all studies on ClinicalTrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/search\/map. Accessed August 5, 2020."},{"key":"3867_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/COH.0000000000000534","volume":"14","author":"N Bbosa","year":"2019","unstructured":"Bbosa N, Kaleebu P, Ssemwanga D. HIV subtype diversity worldwide. Curr Opin HIV AIDS. 2019;14:153\u201360.","journal-title":"Curr Opin HIV AIDS"},{"key":"3867_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1086\/428405","volume":"191","author":"PB Gilbert","year":"2005","unstructured":"Gilbert PB, Peterson ML, Follmann D, et al. Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial. J Infect Dis. 2005;191:666\u201377.","journal-title":"J Infect Dis"},{"key":"3867_CR6","doi-asserted-by":"crossref","unstructured":"de BG. Cofactors that may influence vaccine responses. Curr Opin HIV AIDS. 2010; 5:404\u20138.","DOI":"10.1097\/COH.0b013e32833d1fca"},{"key":"3867_CR7","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1086\/425518","volume":"190","author":"DC Montefiori","year":"2004","unstructured":"Montefiori DC, Metch B, McElrath MJ, Self S, Weinhold KJ, Corey L. Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. J Infect Dis. 2004;190:1962\u20139.","journal-title":"J Infect Dis"},{"issue":"3","key":"3867_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.chom.2016.02.002","volume":"19","author":"BF Haynes","year":"2016","unstructured":"Haynes BF, Shaw GM, Korber B, et al. HIV-host interactions: implications for vaccine design. Cell Host Microbe. 2016;19(3):292\u2013303.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"3867_CR9","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/QAI.0b013e31827e622d","volume":"62","author":"EM Kahle","year":"2013","unstructured":"Kahle EM, Hughes JP, Lingappa JR, et al. An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention. J Acquir Immune Defic Syndr. 2013;62(3):339\u201347.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"3867_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/QAI.0000000000000974","volume":"72","author":"JE Balkus","year":"2016","unstructured":"Balkus JE, Brown E, Palanee T, et al. An empiric HIV risk scoring tool to predict HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2016;72(3):333\u201343.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3867_CR11","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/infdis\/jis342","volume":"206","author":"A Duerr","year":"2012","unstructured":"Duerr A, Huang Y, Buchbinder S, et al. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis. 2012;206(2):258\u201366.","journal-title":"J Infect Dis"},{"issue":"5","key":"3867_CR12","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1473-3099(14)70020-9","volume":"14","author":"GE Gray","year":"2014","unstructured":"Gray GE, Moodie Z, Metch B, et al. Recombinant adenovirus type 5 HIV gag\/pol\/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503\/Phambili study. Lancet Infect Dis. 2014;14(5):388\u201396.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"3867_CR13","doi-asserted-by":"publisher","first-page":"e0137666","DOI":"10.1371\/journal.pone.0137666","volume":"10","author":"Z Moodie","year":"2015","unstructured":"Moodie Z, Metch B, Bekker L-G, et al. Continued follow-up of Phambili Phase 2b randomized HIV-1 vaccine trial participants supports increased HIV-1 acquisition among vaccinated men. PLoS ONE. 2015;10(9):e0137666.","journal-title":"PLoS ONE"},{"key":"3867_CR14","unstructured":"Simbayi LC, Zuma K, Zungu N, et al. South African national HIV prevalence, incidence, behaviour and communication survey, 2017. Available at: http:\/\/www.hsrc.ac.za\/uploads\/pageContent\/9234\/SABSSMV_Impact_Assessment_Summary_ZA_ADS_cleared_PDFA4.pdf. Accessed July 20, 2022."},{"key":"3867_CR15","unstructured":"Shisana O, Rehle T, Simbayi LC, et al. South African national HIV prevalence, incidence and behaviour survey, 2012. Available at: http:\/\/www.hsrc.ac.za\/uploads\/pageContent\/4565\/SABSSM%20IV%20LEO%20final.pdf. Accessed July 20, 2022."},{"issue":"11","key":"3867_CR16","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1371\/journal.pmed.0020298","volume":"2","author":"B Auvert","year":"2005","unstructured":"Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomised, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial. PLOS Med. 2005;2(11):e298:1112\u201322.","journal-title":"PLOS Med"},{"issue":"10","key":"3867_CR17","doi-asserted-by":"publisher","first-page":"e1001","DOI":"10.1371\/journal.pone.0001001","volume":"2","author":"L Chen","year":"2007","unstructured":"Chen L, Jha P, Stirling B, et al. Sexual risk factors for HIV infection in early and advanced HIV epidemics in sub-Saharan Africa: Systematic overview of 68 epidemiological studies. PLoS ONE. 2007;2(10):e1001.","journal-title":"PLoS ONE"},{"issue":"6","key":"3867_CR18","doi-asserted-by":"publisher","first-page":"e2443","DOI":"10.1371\/journal.pone.0002443","volume":"3","author":"C Mattson","year":"2008","unstructured":"Mattson C, Campbell R, Bailer R, Agot K, Ndinya-Achola JO, Moses S. Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multifaceted assessment of men enrolled in a randomized controlled trial. PLoS ONE. 2008;3(6):e2443.","journal-title":"PLoS ONE"},{"key":"3867_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11121-006-0061-2","volume":"8","author":"SC Kalichman","year":"2007","unstructured":"Kalichman SC, Simbayi LC, Kaufman M, Cain D, Jooste S. Alcohol use and sexual risks for HIV\/AIDS in sub-Saharan Africa: Systematic review of empirical findings. Prev Sci. 2007;8:141\u201351.","journal-title":"Prev Sci"},{"issue":"2","key":"3867_CR20","first-page":"175","volume":"6","author":"G Msamanga","year":"2009","unstructured":"Msamanga G, Tchetgen E, Spiegelman D, et al. Determinants of condom use among antenatal clinic attendees in Dar es Salaam, Tanzania. East Afr J of Public Health. 2009;6(2):175\u201383.","journal-title":"East Afr J of Public Health"},{"key":"3867_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.socscimed.2005.05.031","volume":"62","author":"NK Morojele","year":"2006","unstructured":"Morojele NK, Kachieng\u2019a MA, Mokoko E, Nkoko MA, Parry CDH, Nkowane AM. Alcohol use and sexual behaviour among risky drinkers and bar and shebeen patrons in Gauteng province, South Africa. Soc Sci and Med. 2006;62:217\u201327.","journal-title":"Soc Sci and Med"},{"key":"3867_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1360-0443.2008.02500.x","volume":"104","author":"C Parry","year":"2009","unstructured":"Parry C, Rehm J, Poznyak V, Room R. Alcohol and infectious diseases: an overlooked causal linkage? Addiction. 2009;104:331\u20132.","journal-title":"Addiction"},{"key":"3867_CR23","unstructured":"Centers for Disease Control. Revised guidelines for HIV counseling, testing, and referral February 18\u201319, 1999. Available at: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5019a1.htm#box2. Accessed August 20, 2020."},{"issue":"9","key":"3867_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.15537\/smj.2016.9.14519","volume":"37","author":"A Alkhenizan","year":"2016","unstructured":"Alkhenizan A, Elabd K. Non-therapeutic infant male circumcision. Evidence, ethics, and international law perspectives. Saudi Med J. 2016;Sep;37(9):941\u20137.","journal-title":"Saudi Med J"},{"key":"3867_CR25","doi-asserted-by":"crossref","unstructured":"Gray G, Doherty T, Mohapi L, et al. HIV research in South Africa: advancing life. S Afr Med J. 2019; Dec 5;109(11b):36\u201340.","DOI":"10.7196\/SAMJ.2019.v109i11b.14264"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03867-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-022-03867-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-022-03867-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T15:13:45Z","timestamp":1679584425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-022-03867-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["3867"],"URL":"https:\/\/doi.org\/10.1007\/s10461-022-03867-3","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"type":"print","value":"1090-7165"},{"type":"electronic","value":"1573-3254"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"14 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the University of the Witwatersrand Human Research Ethics Committee. Participants provided informed consent voluntarily and in writing for their respective clinical trials.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}